Fasting Study of Alendronate Sodium Tablets (70 mg) and Fosamax Tablets (70 mg)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The objective of this study is to investigate the bioequivalence of Mylan\'s alendronate sodium 70 mg tablets to Merck\'s Fosamax 70 mg tablets following a single, oral 70 mg (1 x 70 mg) dose administration under fasting conditions.
Epistemonikos ID: 75e20c895b2b51848bd8725ee1698ae85c894891
First added on: May 05, 2024